121 related articles for article (PubMed ID: 36121076)
41. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma.
Liu X; Luo HN; Tian WD; Lu J; Li G; Wang L; Zhang B; Liang BJ; Peng XH; Lin SX; Peng Y; Li XP
Cancer Biol Ther; 2013 Dec; 14(12):1133-42. PubMed ID: 24025417
[TBL] [Abstract][Full Text] [Related]
42. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
[TBL] [Abstract][Full Text] [Related]
43. MiR-29c regulates the expression of miR-34c and miR-449a by targeting DNA methyltransferase 3a and 3b in nasopharyngeal carcinoma.
Niu M; Gao D; Wen Q; Wei P; Pan S; Shuai C; Ma H; Xiang J; Li Z; Fan S; Li G; Peng S
BMC Cancer; 2016 Mar; 16():218. PubMed ID: 26975503
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA LUADT1 promotes nasopharyngeal carcinoma cell proliferation and invasion by downregulating miR-1207-5p.
Jiang N; Zhao L; Zong D; Yin L; Wu L; Chen C; Song X; Zhang Q; Jiang X; He X; Feng J
Bioengineered; 2021 Dec; 12(2):10716-10728. PubMed ID: 34738862
[TBL] [Abstract][Full Text] [Related]
45. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
46. Identification of a novel microRNA profile including miR-106b, miR-17, miR-20b, miR-18a and miR-93 in the metastasis of nasopharyngeal carcinoma.
Zhou W; Chang A; Zhao H; Ye H; Li D; Zhuo X
Cancer Biomark; 2020; 27(4):533-539. PubMed ID: 32083569
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis.
Huang T; Yin L; Wu J; Gu JJ; Wu JZ; Chen D; Yu HL; Ding K; Zhang N; Du MY; Qian LX; Lu ZW; He X
J Exp Clin Cancer Res; 2016 Dec; 35(1):188. PubMed ID: 27919278
[TBL] [Abstract][Full Text] [Related]
48. The Role of hsa-miR-21 and Its Target Genes Involved in Nasopharyngeal Carcinoma.
Lao TD; Quang MT; Le TAH
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4075-4083. PubMed ID: 34967592
[TBL] [Abstract][Full Text] [Related]
49. Consistent high concentration of the viral microRNA BART17 in plasma samples from nasopharyngeal carcinoma patients--evidence of non-exosomal transport.
Gourzones C; Ferrand FR; Amiel C; Vérillaud B; Barat A; Guérin M; Gattolliat CH; Gelin A; Klibi J; Chaaben AB; Schneider V; Guemira F; Guigay J; Lang P; Jimenez-Pailhes AS; Busson P
Virol J; 2013 Apr; 10():119. PubMed ID: 23590857
[TBL] [Abstract][Full Text] [Related]
50. Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing.
Wang HY; Yan LX; Shao Q; Fu S; Zhang ZC; Ye W; Zeng YX; Shao JY
Clin Chem; 2014 May; 60(5):773-82. PubMed ID: 24563490
[TBL] [Abstract][Full Text] [Related]
51. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
52. Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma.
Le TAH; Lao TD
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885944
[TBL] [Abstract][Full Text] [Related]
53. Plasma microRNA profiling in nasopharyngeal carcinoma patients reveals miR-548q and miR-483-5p as potential biomarkers.
Zheng XH; Cui C; Ruan HL; Xue WQ; Zhang SD; Hu YZ; Zhou XX; Jia WH
Chin J Cancer; 2014 Jul; 33(7):330-8. PubMed ID: 24874644
[TBL] [Abstract][Full Text] [Related]
54. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
Yi L; Ouyang L; Wang S; Li SS; Yang XM
J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
[TBL] [Abstract][Full Text] [Related]
55. MiR-17-5p promotes cancer cell proliferation and tumorigenesis in nasopharyngeal carcinoma by targeting p21.
Chen C; Lu Z; Yang J; Hao W; Qin Y; Wang H; Xie C; Xie R
Cancer Med; 2016 Dec; 5(12):3489-3499. PubMed ID: 27774777
[TBL] [Abstract][Full Text] [Related]
56. microRNA expression profiling of nasopharyngeal carcinoma.
Li T; Chen JX; Fu XP; Yang S; Zhang Z; Chen KhH; Li Y
Oncol Rep; 2011 May; 25(5):1353-63. PubMed ID: 21373758
[TBL] [Abstract][Full Text] [Related]
57. Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3.
Zheng ZQ; Li ZX; Zhou GQ; Lin L; Zhang LL; Lv JW; Huang XD; Liu RQ; Chen F; He XJ; Kou J; Zhang J; Wen X; Li YQ; Ma J; Liu N; Sun Y
Cancer Res; 2019 Sep; 79(18):4612-4626. PubMed ID: 31331909
[TBL] [Abstract][Full Text] [Related]
58. Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High-Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
Xue N; Lin JH; Xing S; Liu D; Li SB; Lai YZ; Wang XP; Mao MJ; Zhong Q; Zeng MS; Liu WL
Cancer Res Treat; 2019 Jan; 51(1):378-390. PubMed ID: 29807404
[TBL] [Abstract][Full Text] [Related]
59. Effects of Dicer1 targeted by EBV-miR-BART6-5p on biological properties and radiosensitivity of nasopharyngeal carcinoma.
Tang J; Liu ZY; Tang Y; Wang Y
Hum Exp Toxicol; 2021 Jun; 40(6):977-993. PubMed ID: 33305599
[TBL] [Abstract][Full Text] [Related]
60. Circulating Tumor Cells and Fibronectin 1 in the Prognosis of Nasopharyngeal Carcinoma.
Yu Y; Lin ZX; Li HW; Luo HQ; Yang DH; Zhou HC; Jiang DX; Zhan DC; Yang L; Liang XY; Yu ZH; Chen ZH
Technol Cancer Res Treat; 2020; 19():1533033820909911. PubMed ID: 32281480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
